Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Crown Bioscience has enhanced its existing portfolio of humanized drug target models by launching a new transgenic CD3E model to advance development of immuno-oncology drugs.
read more
Wednesday, March 27, 2019
Crown Bioscience announced that parent company, JSR Corporation, has entered into a strategic partnership with Hubrecht Organoid Technology (HUB).
read more
Tuesday, November 18, 2025
CRScube has announced the successful acquisition of Mednet. The transaction unites two respected eClinical technology vendors with complementary strengths and a shared commitment to thoughtful innovation, collaboration, and care for the people behind...
read more
Friday, February 05, 2021
Reflect Scientific has announced a new ultra-low temperature freezer addition to the Cryometrix product line that can be rapidly deployed in a transportable, self-powered configuration.
read more
Cryoport, Inc. has acquired Cell&Co BioServices, headquartered in Clermont-Ferrand, France with additional operations in Pont-du-Château, France.
read more
Acquisition Further Expands Cryoport's Presence in Asia-Pacific Region to Address Increased Clinical Trial Activity Worldwide.
read more
Thursday, January 27, 2022
Cryoport, Inc. has entered into a strategic partnership with Cell Matters, S.A. to deliver to the life sciences industry end-to-end cryopreservation services for leukapheresis derived therapies supporting both autologous and allogeneic cell therapies...
read more
Friday, September 23, 2016
Cryoport has announced the integration of its proprietary logistics technology, the Cryoportal™, with Database Integrations, Inc.'s Integrated Cell Therapy Automated Network (iCAN) scheduling platform.
read more
Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, partners with LifeConEx, a part of DHL Global Forwarding, to enhance and supplement DHL’s cold chain logistics offerings including DHL ...
read more
Thursday, October 24, 2024
Cryoport, Inc. and Gulf Coast Regional Blood Center, a non-profit community blood center serving more than 26 counties throughout the state of Texas, announced a strategic alliance to enhance the availability of high-quality, manufacture-ready ...
read more
Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, and Mitsubishi Logistics Corporation ("MLC"), ...
read more
Cryoport, Inc. has announced the launch of a new Temperature Controlled Logistics Consulting Division to assist life sciences companies in developing strategies for global cold chain logistics management and contingency options to protect their ...
read more
Cryoport, Inc. announced a multi-year agreement with Inception Fertility™. Inception Fertility operates The Prelude Network® (Prelude), a network of fertility centers in North America, and MyEggBank®, a network of donor egg banks and practices in ...
read more
Thursday, January 19, 2023
Cryoport, Inc. announced a new strategic partnership with Syneos Health® that will support the global advancement of cell and gene therapies, providing a fully integrated biopharmaceutical and supply chain solution.
read more
Dr. Hariri is the Chairman, Founder and Chief Scientific Officer of Celgene Cellular Therapeutics, one of the world's largest human cellular therapeutics companies and wholly owned subsidiary of Celgene Corporation.
read more